683 related articles for article (PubMed ID: 27083288)
1. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
3. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
4. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
[TBL] [Abstract][Full Text] [Related]
5. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.
Stubbs JR; House JA; Ocque AJ; Zhang S; Johnson C; Kimber C; Schmidt K; Gupta A; Wetmore JB; Nolin TD; Spertus JA; Yu AS
J Am Soc Nephrol; 2016 Jan; 27(1):305-13. PubMed ID: 26229137
[TBL] [Abstract][Full Text] [Related]
6. Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.
Guo F; Dai Q; Zeng X; Liu Y; Tan Z; Zhang H; Ouyang D
Int Urol Nephrol; 2021 Mar; 53(3):539-551. PubMed ID: 32945995
[TBL] [Abstract][Full Text] [Related]
7. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
Pelletier CC; Croyal M; Ene L; Aguesse A; Billon-Crossouard S; Krempf M; Lemoine S; Guebre-Egziabher F; Juillard L; Soulage CO
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31683880
[TBL] [Abstract][Full Text] [Related]
8. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
[TBL] [Abstract][Full Text] [Related]
10. Trimethylamine-
Zheng Y; Tang Z; You L; Wu Y; Liu J; Xue J
Ren Fail; 2020 Nov; 42(1):580-586. PubMed ID: 32576072
[No Abstract] [Full Text] [Related]
11. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
12. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
14. The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada.
Mente A; Chalcraft K; Ak H; Davis AD; Lonn E; Miller R; Potter MA; Yusuf S; Anand SS; McQueen MJ
Can J Cardiol; 2015 Sep; 31(9):1189-94. PubMed ID: 26239008
[TBL] [Abstract][Full Text] [Related]
15. Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease.
Tatami Y; Yasuda Y; Suzuki S; Ishii H; Sawai A; Shibata Y; Ota T; Shibata K; Niwa M; Morimoto R; Hayashi M; Kato S; Maruyama S; Murohara T
Atherosclerosis; 2015 Dec; 243(2):349-55. PubMed ID: 26519631
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Plasma Trimethylamine N-Oxide Levels and Renal Dysfunction in Patients with Hypertension.
Zhou J; Wang D; Li B; Li X; Lai X; Lei S; Li N; Zhang X
Kidney Blood Press Res; 2021; 46(4):421-432. PubMed ID: 34233325
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
[TBL] [Abstract][Full Text] [Related]
18. The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease.
Tomlinson JAP; Wheeler DC
Kidney Int; 2017 Oct; 92(4):809-815. PubMed ID: 28807612
[TBL] [Abstract][Full Text] [Related]
19. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
[TBL] [Abstract][Full Text] [Related]
20. The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study.
Cseprekál O; Egresits J; Tabák Á; Nemcsik J; Járai Z; Babos L; Fodor E; Farkas K; Godina G; Kárpáthi KI; Kerkovits L; Marton A; Nemcsik-Bencze Z; Németh Z; Sallai L; Kiss I; Tislér A
J Hum Hypertens; 2016 Jul; 30(7):449-55. PubMed ID: 26424101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
